micro dosing glp 1 THE PCCA BLOG Microdosing GLP-1s Is Gaining Popularity—But

It's the reality of the world we live in now

They also calm inflammation , a hidden trigger for many chronic illnesses, including heart disease, fatty liver, and metabolic syndrome

The most well-known GLP-1 drugs include: Ozempic (semaglutide) - FDA-approved for Type 2 diabetes Wegovy (semaglutide) - FDA-approved for chronic weight management and cardiovascular risk reduction Mounjaro (tirzepatide) - FDA-approved for Type 2 diabetes Zepbound (tirzepatide) - FDA-approved for chronic weight management and obstructive sleep apnea Foundayo (orforglipron) - a newer oral GLP-1 option Here's an important detail many people miss: Ozempic and Wegovy contain the exact same active ingredient (semaglutide), made by the same manufacturer (Novo Nordisk)

The answer depends primarily on the specific medication and formulation prescribed

Despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control, said the researchers